what is glp-1 microdosing Microdosing GLP-1
Description
That is more than enough
But there are important qualifications
Some GLP-1 medications have demonstrated renal protective effects in clinical trials, though evidence varies by specific agent
Effects of Glucagon-like Peptide-1 on Endothelial Function in Type 2 Diabetes Patients with Stable Coronary Artery Disease
Clinical trial data from the STEP and SURMOUNT programs demonstrate that maximum weight loss typically occurs between 60-72 weeks of treatment, with most patients losing 1-2 pounds per week during the active weight loss phase
